Global Bio-chem Technology Group Company Limited
GBCMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $676 | $1,335 | $1,511 | $1,104 |
| - Cash | $85 | $88 | $42 | $22 |
| + Debt | $3,691 | $5,450 | $8,153 | $8,444 |
| Enterprise Value | $4,282 | $6,697 | $9,623 | $9,527 |
| Revenue | $2,001 | $1,374 | $13 | $747 |
| % Growth | 45.6% | 10,709% | -98.3% | – |
| Gross Profit | $219 | $44 | $8 | $48 |
| % Margin | 10.9% | 3.2% | 62.1% | 6.5% |
| EBITDA | $17 | -$43 | -$469 | $786 |
| % Margin | 0.8% | -3.2% | -3,690.2% | 105.2% |
| Net Income | $770 | $4,225 | -$1,443 | -$401 |
| % Margin | 38.5% | 307.5% | -11,352.9% | -53.7% |
| EPS Diluted | 4.3 | 23.5 | -8 | -2.25 |
| % Growth | -81.7% | 393.8% | -255.6% | – |
| Operating Cash Flow | $76 | -$50 | -$88 | -$475 |
| Capital Expenditures | $0 | -$44 | -$6 | -$26 |
| Free Cash Flow | $76 | -$94 | -$94 | -$501 |